NIH Treatment Guideline Update: “there are insufficient data to recommend either for or against the use of tocilizumab or sarilumab for the treatment of COVID-19”
The COVID-19 Treatment Guidelines Panel’s Statement on the Use of Tocilizumab (and Other Interleukin-6 Inhibitors) for the Treatment of COVID-19 – National Institutes of Health
The post NIH Treatment Guideline Update: “there are insufficient data to recommend either for or against the use of tocilizumab or sarilumab for the treatment of COVID-19” appeared first on Links Medicus.
Systematic review: Telerehabilitation for chronic respiratory disease
Telerehabilitation for chronic respiratory disease – Cochrane Library Summary: How does using technology to deliver pulmonary rehabilitation (PR) compare to centre-based PR, or no PR in people with chronic lung disease? – Cochrane Library
The post Systematic review: Telerehabilitation for chronic respiratory disease appeared first on Links Medicus.
Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys
Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys – The Lancet Child & Adolescent Health (link to abstract – $ for full-text) Commentary on Twitter NEW—Global Youth Tobacco Surveys data from 13–15-year-olds in 140 countries, suggests 40% of countries show […]
The post Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys appeared first on Links Medicus.
Systematic review: No evidence that patients with asthma are at increased risk of COVID-19 diagnosis, hospitalization or death
Asthma in Adult Patients with COVID-19: Prevalence and Risk of Severe Disease – American Journal of Respiratory and Critical Care Medicine Commentary: Asthma Patients Get Reassurance on COVID-19 — Research review finds no firm evidence of increased risk for severe illness, death – MedPage Today
The post Systematic review: No evidence that patients with asthma are at increased risk of COVID-19 diagnosis, hospitalization or death appeared first on Links Medicus.
[Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19
More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis – medRxiv Commentary: 80% of COVID-19 Patients May Have Lingering Symptoms, Signs — More than 50 effects persisted after acute infection, meta-analysis shows – MedPage Today (free registration required)
The post [Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19 appeared first on Links Medicus.
UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus
UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus – Biobank Commentary: Covid: Antibodies last at least six months in most – BBC
The post UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus appeared first on Links Medicus.
Study shows the viral load of index cases is a leading driver of SARS-CoV-2 transmission
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study – The Lancet Infectious Diseases Commentary: Understanding the drivers of transmission of SARS-CoV-2 – The Lancet Infectious Diseases
The post Study shows the viral load of index cases is a leading driver of SARS-CoV-2 transmission appeared first on Links Medicus.
RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet Invited Commentary: Azithromycin, RECOVERY, and the power of large, simple trials – The Lancet
The post RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19 appeared first on Links Medicus.
Covid-19: People who have had infection might only need one dose of mRNA vaccine
Covid-19: People who have had infection might only need one dose of mRNA vaccine – The BMJ Original preprint studies: Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine – medRxiv AND Single Dose Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2 – medRxiv
The post Covid-19: People who have had infection might only need one dose of mRNA vaccine appeared first on Links Medicus.
Russia’s Sputnik V COVID-19 vaccine candidate appears safe and is 91.6% effective
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia – The Lancet Commentaries: Sputnik V COVID-19 vaccine candidate appears safe and effective – The Lancet AND Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed […]
The post Russia’s Sputnik V COVID-19 vaccine candidate appears safe and is 91.6% effective appeared first on Links Medicus.